OECD Home › Science and technology › Science and technology policy › Latest Documents
As biotechnology becomes increasingly viewed as a strategic sector, the need for reliable statistics from which informed policy decisions can be made grows. This report provides an update on the biotechnology industry, based on primarily official statistical sources.
This report addresses issues related to governance of public research, describes the challenges and provides evidence of the reforms that have been developed. Good practices are highlighted and policy lessons are drawn.
As far as we know, there is no study that identifies databases on the destination of doctorate recipients, including at international level. This report has two objectives: to review existing statistical sources in the OECD countries, and discuss their comparability.
This paper examines the factors that have contributed to the growing popularity of R&D spending targets and analyses in more detail the economic and structural consequences of achieving the increased levels of R&D spending.
This paper examines recent patterns in productivity growth of service industries and analyses the role of problems in measuring service productivity growth on industry and aggregate productivity growth.
This paper reviews a set of recommendations describing a harmonised method for estimating software.
This paper provides input and a framework for a broader discussion of the identification of user needs that should inform the development of biotechnology statistics and indicators.
This publication contains survey data on academic patenting and licensing and several case studies on the policies and practices for managing intellectual property.
This document reports findings regarding the use of patents data for understanding various dimensions of technical change in health-related areas.
English, , 669kb
This report presents the findings of an OECD Workshop held in Berlin to establish the impact of patents and licensing on development and access to genetic technology. Few topics in the life sciences today provoke as much debate as the availability of patent protection on "genetic inventions".